Drug Shortage Report for APO-CEFEPIME

Last updated on 2021-08-06 History
Report ID 140772
Drug Identification Number 02467518
Brand name APO-CEFEPIME
Common or Proper name CEFEPIME
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CEFEPIME
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20 ML
ATC code J01DE
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-06-08
Estimated end date 2021-08-06
Actual end date 2021-08-04
Shortage status Resolved
Updated date 2021-08-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-08-06 French Compare
v11 2021-08-06 English Compare
v10 2021-07-30 French Compare
v9 2021-07-30 English Compare
v8 2021-07-14 French Compare
v7 2021-07-14 English Compare
v6 2021-06-21 French Compare
v5 2021-06-21 English Compare
v4 2021-06-17 French Compare
v3 2021-06-17 English Compare
v2 2021-06-11 French Compare
v1 2021-06-11 English Compare

Showing 1 to 12 of 12